title: Use of octreotide in the management of severe duodenal bleeding after unrelated-donor bone marrow transplantation.
authors.forename: Kazuteru
authors.initials: K
authors.lastname: Ohashi
authors.forename: Masaki
authors.initials: M
authors.lastname: Sanaka
authors.forename: Yuji
authors.initials: Y
authors.lastname: Tanaka
authors.forename: Yoshiki
authors.initials: Y
authors.lastname: Okuyama
authors.forename: Kiyoshi
authors.initials: K
authors.lastname: Hiruma
authors.forename: Hideki
authors.initials: H
authors.lastname: Akiyama
authors.forename: Hisashi
authors.initials: H
authors.lastname: Sakamaki
mesh_terms: D000328:Adult; D016026:Bone Marrow Transplantation; D004378:Duodenal Diseases / Q000188:drug therapy / Q000209:etiology; D005260:Female; D005765:Gastrointestinal Agents / Q000008:administration & dosage*; D006471:Gastrointestinal Hemorrhage / Q000188:drug therapy* / Q000209:etiology; D006086:Graft vs Host Disease / Q000150:complications; D006801:Humans; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000628:therapy*; D015282:Octreotide / Q000008:administration & dosage*; D014019:Tissue Donors
chemical_list: D005765:Gastrointestinal Agents; D015282:Octreotide